Congress Materials – Academy of Managed Care Pharmacy Nexus (AMCP Nexus 2025)
2025 Academy of Managed Care Pharmacy Nexus | Oct 27-30 | National Harbor, MD
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
An Economic Model Assessing Costs, Relapses, and Antipsychotic Adherence of Switching Medicaid Beneficiaries With Schizophrenia From Oral Antipsychotics to Once-Monthly, Once-Every-Three-Months, and Once-Every-Six-Months Paliperidone Palmitate
Carmela Benson, Laura Morrison, Béatrice Libchaber, Lilian Diaz, Yuxian Du, Dominic Pilon
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
